OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Behavioral and cellular dopamine D1 and D3 receptor-mediated synergy: Implications for L-DOPA-induced dyskinesia
Kathryn Lanza, Samantha M. Meadows, Nicole Chambers, et al.
Neuropharmacology (2018) Vol. 138, pp. 304-314
Open Access | Times Cited: 37
Kathryn Lanza, Samantha M. Meadows, Nicole Chambers, et al.
Neuropharmacology (2018) Vol. 138, pp. 304-314
Open Access | Times Cited: 37
Showing 26-50 of 37 citing articles:
Targeting the receptor-based interactome of the dopamine D1 receptor: looking for heteromer-selective drugs
Verònica Casadó-Anguera, Antoni Cortés, Vicent Casadó, et al.
Expert Opinion on Drug Discovery (2019) Vol. 14, Iss. 12, pp. 1297-1312
Closed Access | Times Cited: 10
Verònica Casadó-Anguera, Antoni Cortés, Vicent Casadó, et al.
Expert Opinion on Drug Discovery (2019) Vol. 14, Iss. 12, pp. 1297-1312
Closed Access | Times Cited: 10
Shedding light on dyskinesias
Iván Castela, Ledia F. Hernández
European Journal of Neuroscience (2020) Vol. 53, Iss. 7, pp. 2398-2413
Closed Access | Times Cited: 9
Iván Castela, Ledia F. Hernández
European Journal of Neuroscience (2020) Vol. 53, Iss. 7, pp. 2398-2413
Closed Access | Times Cited: 9
Reciprocal cross-sensitization of D1 and D3 receptors following pharmacological stimulation in the hemiparkinsonian rat
Kathryn Lanza, Katherine Chemakin, Sarah Lefkowitz, et al.
Psychopharmacology (2019) Vol. 237, Iss. 1, pp. 155-165
Closed Access | Times Cited: 9
Kathryn Lanza, Katherine Chemakin, Sarah Lefkowitz, et al.
Psychopharmacology (2019) Vol. 237, Iss. 1, pp. 155-165
Closed Access | Times Cited: 9
Severity of Dyskinesia and D3R Signaling Changes Induced by L-DOPA Treatment of Hemiparkinsonian Rats Are Features Inherent to the Treated Subjects
Sacnité Albarrán‐Bravo, José Arturo Ávalos‐Fuentes, Hernán Cortés, et al.
Biomolecules (2019) Vol. 9, Iss. 9, pp. 431-431
Open Access | Times Cited: 7
Sacnité Albarrán‐Bravo, José Arturo Ávalos‐Fuentes, Hernán Cortés, et al.
Biomolecules (2019) Vol. 9, Iss. 9, pp. 431-431
Open Access | Times Cited: 7
Recent Advances in Dopamine D3 Receptor Heterodimers: Focus on Dopamine D3 and D1 Receptor–Receptor Interaction and Striatal Function
Federica Bono, Veronica Mutti, Zaira Tomasoni, et al.
Current topics in behavioral neurosciences (2022), pp. 47-72
Closed Access | Times Cited: 4
Federica Bono, Veronica Mutti, Zaira Tomasoni, et al.
Current topics in behavioral neurosciences (2022), pp. 47-72
Closed Access | Times Cited: 4
Loss of Function in Dopamine D3 Receptor Attenuates Left Ventricular Cardiac Fibroblast Migration and Proliferation in vitro
Andrew Kisling, Shannon E Byrne, Rohan Umesh Parekh, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 5
Andrew Kisling, Shannon E Byrne, Rohan Umesh Parekh, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 5
In Vitro and In Silico Characterization of Kurarinone as a Dopamine D1A Receptor Antagonist and D2L and D4 Receptor Agonist
Ritu Prajapati, Su Hui Seong, Pradeep Paudel, et al.
ACS Omega (2021) Vol. 6, Iss. 49, pp. 33443-33453
Open Access | Times Cited: 5
Ritu Prajapati, Su Hui Seong, Pradeep Paudel, et al.
ACS Omega (2021) Vol. 6, Iss. 49, pp. 33443-33453
Open Access | Times Cited: 5
Dopamine receptor cooperativity synergistically drives dyskinesia, motor behavior, and striatal GABA neurotransmission in hemiparkinsonian rats
Corinne Y. Kiessling, Kathryn Lanza, Evan N. Feinberg, et al.
Neuropharmacology (2020) Vol. 174, pp. 108138-108138
Closed Access | Times Cited: 4
Corinne Y. Kiessling, Kathryn Lanza, Evan N. Feinberg, et al.
Neuropharmacology (2020) Vol. 174, pp. 108138-108138
Closed Access | Times Cited: 4
Pharmacological targeting of dopamine D1 or D2 receptors evokes a rapid‐onset parkinsonian motor phenotype in mice
Christian del Agua Villa, Mihai Atudorei, Hartwig R. Siebner, et al.
European Journal of Neuroscience (2024)
Open Access
Christian del Agua Villa, Mihai Atudorei, Hartwig R. Siebner, et al.
European Journal of Neuroscience (2024)
Open Access
Selective D2 and D3 receptor antagonists oppositely modulate cocaine responses in mice via distinct postsynaptic mechanisms in nucleus accumbens
Daniel F. Manvich, Alyssa K. Petko, Rachel C. Branco, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2018)
Open Access | Times Cited: 1
Daniel F. Manvich, Alyssa K. Petko, Rachel C. Branco, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2018)
Open Access | Times Cited: 1
Future Directions for Developing Non-dopaminergic Strategies for the Treatment of Parkinson’s Disease
Daniel J. van Wamelen, Valentina Leta, К. Ray Chaudhuri, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 10, pp. 1606-1620
Closed Access
Daniel J. van Wamelen, Valentina Leta, К. Ray Chaudhuri, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 10, pp. 1606-1620
Closed Access
Dopamine receptor DOP-1 engages a sleep pathway to modulate swimming inC. elegans
Ye Xu, Lin Zhang, Yan Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Ye Xu, Lin Zhang, Yan Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
